Showing results (1501-1510 of 3,637) with videos related to
Sort By:
Pageof 364
Breast (Edinburgh, Scotland)|April 5, 2020
Reduced symptom burden with the support of an interactive app during neoadjuvant chemotherapy for breast cancer - A randomized controlled trialMaria Fjell, Ann Langius-Eklöf, Marie Nilsson, et al.Breast (Edinburgh, Scotland)|January 25, 2020
Improving breast cancer care coordination and symptom management by using AI driven predictive toolkitsE C Moser, Gayatri NarayanBreast (Edinburgh, Scotland)|January 26, 2020
Invasive breast cancer over four decades reveals persisting poor metastatic outcomes in treatment resistant subgroup - the "ATRESS" phenomenonPatriek Jurrius, Thomas Green, Hans Garmo, et al.Breast (Edinburgh, Scotland)|March 23, 2020
Dual HER2 blockade in the first-line treatment of metastatic breast cancer - A retrospective population-based observational study in Danish patientsThomas Christensen, Tobias Berg, Lise Birk Nielsen, et al.Breast (Edinburgh, Scotland)|March 16, 2020
Evaluation of the 8th edition of the American joint committee on cancer's pathological staging system in prognosis assessment and treatment decision making for stage T1-2N1 breast cancer after mastectomySan-Gang Wu, Jun Wang, Chen-Lu Lian, et al.Breast (Edinburgh, Scotland)|December 3, 2019
Decision of adjuvant chemotherapy in intermediate risk luminal breast cancer patients: A prospective multicenter trial assessing the clinical and psychological impact of EndoPredict® (EpClin) use (UCBG 2-14)Frédérique Penault-Llorca, Fabrice Kwiatkowski, Antoine Arnaud, et al.Breast (Edinburgh, Scotland)|September 21, 2020
Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in GermanyAndreas Schneeweiss, Johannes Ettl, Diana Lüftner, et al.Breast (Edinburgh, Scotland)|September 21, 2020
Orthotopic grafting of decellularized human nipple: Setting the stage and putative mechanism of healingPeter C Johnson, Gerald L KleinBreast (Edinburgh, Scotland)|November 26, 2020
A randomized trial of individualized versus standard of care antiemetic therapy for breast cancer patients at high risk for chemotherapy-induced nausea and vomitingM Clemons, G Dranitsaris, M Sienkiewicz, et al.Breast (Edinburgh, Scotland)|November 26, 2020
Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP)Luis Manso, Cristina Hernando, María Galán, et al.Pageof 364